跳至主要内容
临床试验/NCT01126359
NCT01126359已完成不适用

Lidocaine Analgesia For Removal Of Wound Vacuum Assisted Closure Dressings: A Randomized Double Blinded Controlled Trial

University of Utah1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2008年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
11
试验地点
1
主要终点
Visual Analog Scale Pain Score

研究概览

简要总结

The purpose of this prospective study is to compare pain levels and pain medication dose requirements in patients with topical negative pressure (TNP) dressings removed in a standard manner (i.v. or p.o. pain meds) compared to dressings removed with lidocaine analgesia, via injection retrograde up the suction tube into the foam prior to removal. Our null hypothesis is that there will be no difference in overall pain scores or medication requirements when patients receive a saline, control injection and pain medications, compared to when their dressings are changed with a lidocaine injection into the sponge, with pain medications. Our objective is to disprove this null hypothesis with statistical significance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • wounds to which a split-thickness autologous skin graft applied;
  • infected wounds after debridement;
  • open fracture wounds;
  • acute soft-tissue wounds (with exposed tendon, bone, hardware, and/or joint);
  • fasciotomy wounds after compartment syndrome;
  • chronic non-healing wounds;
  • surgical wounds that are difficult to close due to tension; or
  • wounds with external fixation pins or tubes with irritation or drainage.

排除标准

  • allergy to lidocaine;
  • allergy to the polyurethane foam or impermeable seal;
  • malignancy associated with the wound;
  • extremity insensate to pain due to any cause (including diabetic neuropathy, or any neurologic disorder therein);
  • pregnancy as diagnosed by urine pregnancy test.

研究组 & 干预措施

Lidocaine then Placebo-Saline

Placebo Comparator

干预措施: Lidocaine (Drug)

Lidocaine then Placebo-Saline

Placebo Comparator

干预措施: Placebo-Saline (Drug)

Placebo-Saline then Lidocaine

Active Comparator

干预措施: Lidocaine (Drug)

Placebo-Saline then Lidocaine

Active Comparator

干预措施: Placebo-Saline (Drug)

结局指标

主要结局

Visual Analog Scale Pain Score

时间窗: 20 minutes

Visial Analog Pain Scores (VAS) range from 0 (no pain) - 10 (worst pain ever). Visial Analog Pain Scores are determined at each pain measurement time point (during/after VAC dressing removal).

次要结局

  • Break-through Narcotic Requirement(20 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric Kubiak

M.D.

University of Utah

研究点 (1)

Loading locations...

相似试验